Crossmark

Therapeutic implications of transplanted-cell death

Crossref DOI link: https://doi.org/10.1038/s41551-021-00729-6

Published Online: 2021-05-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wagoner, Zachary W. https://orcid.org/0000-0002-0354-5407
Zhao, Weian
License Information

Text and Data Mining valid from 2021-05-17

Version of Record valid from 2021-05-17
More Information

Article History

First Online: 17 May 2021

Competing interests

: W.Z. is a co-founder of Velox Biosystems Inc., Amberstone Biosciences Inc. and Arvetas Biosciences Inc.